Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Emerging therapeutics for targeting Akt in cancer
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Emerging therapeutics for targeting Akt in cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Protein Kinase B Inhibitor
100%
Effector
60%
Cell Viability
54%
Protein
45%
Medicine & Life Sciences
Protein Isoforms
74%
Neoplasms
35%
Therapeutic Human Experimentation
25%
Proto-Oncogene Proteins c-akt
21%
Therapeutics
18%
Cell Survival
14%
Clinical Studies
12%
Growth
9%
Population
7%
Proteins
6%